Linked Life Data

7194499

Source:http://linkedlifedata.com/resource/pubmed/id/7194499

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1981-6-25
pubmed:abstractText
The pharmacokinetics of ampicillin and two preparations of bacampicillin, Veegum and microcapsules, were studied in 24 infants and children. For bacampicillin, mean peak concentrations of 7.6 and 14.4 micrograms/ml were found in the sera of fasting patients after administration of 27.8 mg of drug/ml in Veegum and microcapsular suspensions, respectively. Bacampicillin (27.8 mg/kg) and ampicillin (25 mg/kg) were compared in crossover fashion in 21 of the 24 children. Although the dosage of bacampicillin was 25% smaller on an equimolar basis than that of ampicillin, drug concentrations in serum were consistently higher with bacampicillin than with ampicillin; the differences were statistically significant 0.5, 1, and 2 hr after administration. The bioavailability of bacampicillin was two-to threefold greater than that of ampicillin. Urinary concentrations of drug were twofold higher with bacampicillin than with ampicillin. The proportion of saliva samples with detectable antimicrobial activity was similar among patients who received bacampicillin (31%) and those who received ampicillin (25%); however, the mean salivary concentrations 2 and 4 hr after administration of bacampicillin were substantially higher than those after ampicillin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0162-0886
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
117-20
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Comparative pharmacokinetics of bacampicillin and ampicillin suspensions in infants and children.
pubmed:publicationType
Journal Article, Comparative Study